Diabetes drug makes lung cancer vulnerable

Status
Not open for further replies.

Northerner

Admin (Retired)
Relationship to Diabetes
Type 1
A diabetes drug has been found to slow the growth of lung cancer cells and make them more vulnerable to radiation, research at McMaster University has found.

Metformin, a drug that is meant for diabetes can play a part in helping treat lung cancer, says Dr. Theodoros Tsakirdis, an assistant professor of Oncology at McMaster University, and a radiation oncologist at the Juravinski Cancer Centre.

?We realized over time that it actually influences molecular mechanisms of cancer cell growth,? says Tsakirdis. ?The reason we have done the research we have done is because we are looking at the mechanisms of action of radiotherapy on cancer cells.?

http://www.cbc.ca/hamilton/news/story/2013/05/01/hamilton-doctor-metformin-cancer-link.html
 
Status
Not open for further replies.
Back
Top